Feed SRTS
SR

Sensus Healthcare, Inc.

SRTS · NASDAQ

$3.07 +0.33% (+$0.01)
1M -12.61%
Market Cap $50.5M
P/E Ratio -
Div. Yield -
ROE 34.09%

Bulios Fair Price

$1.75

43.0% downside

Trenutna cena

$3.07

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica SRTS trenutno precenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Weak
2/9
Valuation
80 /100
Cheap
P/S 2.89x
P/B 1.37x
P/E N/A
Growth
6 /100
Declining
Rev. growth 14.86%
Book val. growth 0.02%
EPS growth N/A
Profitability
14 /100
Weak
Gross margin 36.39%
Net margin 88.45%
Op. margin 75.72%
Quality
5 /100
Poor
ROIC 43.45%
ROE 34.09%
ROA 37.53%
Debt
100 /100
Low
Debt/Equity 0.01x
Current ratio 8.71x
Int. coverage N/A
Stability
18 /100
Unstable
Beta 1.14x
Rev. volatility 64.34%
EPS volatility 828.90%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o SRTS
Online

O podjetju

Sensus Healthcare, Inc. (SRTS) is a company specializing in the development and provision of advanced technologies for the treatment of cancer and dermatological conditions. With over a decade of history, Sensus Healthcare focuses on innovative approaches, such as low-dose radiation therapy, that selectively target tumor cells and minimize effects on surrounding healthy tissues. Their technologies offer patients and physicians alternative treatment options with an emphasis on effectiveness and reduced invasiveness. Sensus Healthcare, Inc. (SRTS) contributes to the advancement of sophisticated treatment methods and the improvement of quality of life for patients with cancer and dermatological conditions. Sensus Healthcare, Inc. (SRTS) shares could be suitable for investors who want to support innovations in oncological and dermatological treatment and contribute to progress in therapeutic approaches.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Devices

CEO

Joseph C. Sardano

Employees

60

Headquarters

Boca Raton

Prihajajoči dogodki

05 NOV.

Earnings

Upcoming earnings report

44d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.